Luciano Wannesson
Bellinzona, TI 6500, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis.
Journal: Swiss medical weekly
Published: August 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Journal: International journal of molecular sciences
Published: February 26, 2024
Prognostic implication of PD-L1 in early-stage non-small cell lung cancer: a retrospective single-centre study.
Journal: Swiss medical weekly
Published: September 28, 2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Journal: Hematological oncology
Published: August 28, 2023
Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 01, 2023
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 01, 2022
Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers.
Journal: Cancers
Published: July 15, 2022
Lurbinectedin improves macular edema in a case of central retinal vein occlusion.
Journal: American journal of ophthalmology case reports
Published: June 18, 2022
Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy.
Journal: Journal of clinical medicine
Published: January 24, 2022
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
Journal: Therapeutic advances in medical oncology
Published: January 16, 2022
Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma.
Journal: BMC cancer
Published: December 08, 2020
Last Updated: 09/26/2026